市場調查報告書
商品編碼
1572465
基於人工智慧的手術機器人市場、機會、成長動力、產業趨勢分析與預測,2024-2032AI-based Surgical Robots Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
2023 年,全球基於人工智慧的手術機器人市場估值為57 億美元。 預測顯示出強勁的成長軌跡,預計2024 年至2032 年複合年成長率為16.2%。技術進步、外科手術的增加程序、支持性政府措施和資金等因素。
微創手術以創傷小、恢復速度快而聞名,擴大採用基於人工智慧的手術機器人。這些機器人提供增強的控制和精確度,這對於此類手術至關重要。例如,Meritas Health 報告稱,美國每年進行超過 1500 萬例腹腔鏡手術。此外,基於人工智慧的手術機器人提高了精確度,降低了人為錯誤風險。這會帶來更好的患者治療效果、降低併發症發生率並縮短住院時間。
將人工智慧融入機器人手術正在徹底改變手術實踐,提高其效率、安全性和有效性。人工智慧整合有助於精細的操作,最大限度地減少組織損傷,縮短恢復時間並提高患者的治療效果。透過簡化操作,人工智慧不僅可以縮短手術時間,還可以在同一時間內進行更多的手術。這種效率在高要求的手術環境中至關重要,可以提高營運吞吐量並控制醫療成本。此外,人工智慧驅動的預測分析和模擬工具支援術前規劃。這些工具使外科醫生能夠可視化不同的場景和結果,為複雜的手術做好準備,減少術中意外並提高手術效果。
基於人工智慧的手術機器人產業根據類型、應用、最終用途和地區進行分類。
2023 年,硬體部門的收入佔有率領先,價值 35 億美元。先進的成像系統,包括 3D 成像、術中成像和即時視覺化工具,對於指導基於人工智慧的手術過程至關重要。隨著對這些高效能成像系統的需求激增,醫療保健提供者擴大採用尖端的硬體技術。其中包括先進的機械手臂、精密儀器和人工智慧整合成像系統,所有這些都旨在提高護理品質。
2023年,醫院佔據73.9%的主導市場。神經外科、心血管外科和腫瘤科等醫院的專業外科服務發現基於人工智慧的手術機器人具有巨大價值。這些機器人在執行需要精確和即時決策的複雜手術中發揮著重要作用。此外,隨著醫院尋求可擴展和適應性強的手術解決方案,基於人工智慧的手術機器人的模組化和可自訂特性成為一個重要的吸引力,特別是對於那些旨在擴大其手術能力的醫院來說。
北美基於人工智慧的手術機器人市場在 2023 年的收入為 38 億美元。 預測顯示 2024 年至 2032 年複合年成長率為 14.9%。為了滿足這種不斷成長的需求,基於人工智慧的手術機器人正在佔據重要地位,特別是在大容量手術中心。此外,北美的監管環境有利於人工智慧手術技術的採用。美國監管機構,特別是 FDA,為包括人工智慧手術機器人在內的醫療設備提供簡化的批准途徑,並加速其市場進入。
The Global AI-based Surgical Robots Market was valued at USD 5.7 billion in 2023. Projections indicate a robust growth trajectory, with an anticipated CAGR of 16.2% from 2024 to 2032. This surge can be largely attributed to technological advancements, an uptick in surgical procedures, and supportive government initiatives and funding, among other factors.
Minimally invasive procedures, known for being less traumatic and promoting quicker recovery, are increasingly adopting AI-based surgical robots. These robots provide enhanced control and precision, crucial for such surgeries. For instance, Meritas Health reports that the U.S. sees over 15 million laparoscopic surgeries annually. Moreover, AI-based surgical robots enhance precision, mitigating human error risks. This leads to superior patient outcomes, reduced complication rates, and shorter hospital stays.
The infusion of AI into robotic surgeries is revolutionizing surgical practices, enhancing their efficiency, safety, and effectiveness. AI integration facilitates delicate maneuvers, minimizing tissue damage, shortening recovery times, and boosting patient outcomes. By streamlining operations, AI not only cuts down surgery durations but also allows for a greater number of procedures in the same timeframe. This efficiency is vital in high-demand surgical environments, enhancing operational throughput and curbing healthcare costs. Furthermore, AI-driven predictive analytics and simulation tools bolster preoperative planning. By enabling surgeons to visualize diverse scenarios and outcomes, these tools prepare them for intricate surgeries, reducing intraoperative surprises and elevating surgical results.
The AI-based surgical robots industry is classified based on type, application, end-use, and region.
In 2023, the hardware segment led the revenue share, valued at USD 3.5 billion. Advanced imaging systems, including 3D imaging, intraoperative imaging, and real-time visualization tools, are pivotal for guiding AI-based surgical procedures. As the demand for these high-performance imaging systems surges, healthcare providers are increasingly adopting cutting-edge hardware technologies. This encompasses advanced robotic arms, precision instruments, and AI-integrated imaging systems, all aimed at elevating care quality.
In 2023, hospitals commanded a dominant market share of 73.9%. Specialized surgical services in hospitals, such as neurosurgery, cardiovascular surgery, and oncology, find immense value in AI-based surgical robots. These robots are instrumental in executing intricate surgeries that demand precision and real-time decision-making. Furthermore, as hospitals seek scalable and adaptable surgical solutions, the modular and customizable nature of AI-based surgical robots becomes a significant draw, especially for those aiming to broaden their surgical capabilities.
North America AI-based surgical robots market held a revenue of USD 3.8 billion in 2023. Projections suggest a CAGR of 14.9% from 2024 to 2032. The region witnesses a consistent rise in surgical procedures, fueled by an aging demographic, increased elective surgeries, and evolving surgical techniques. To cater to this surging demand, AI-based surgical robots are finding a prominent place, especially in high-volume surgical centers. Additionally, the regulatory landscape in North America favors the adoption of AI surgical technologies. U.S. regulatory bodies, notably the FDA, offer streamlined approval pathways for medical devices, including AI-powered surgical robots, expediting their market entry.